News
Mar 31, 2021, 12:00 PM
Two drugs newly marketed in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the QTdrugs list in the Possible Risk of TdP category. They will also be added to the list of Drugs to Avoid for patients with congenital long QT syndrome.